Shaping of tumor and drug-resistant genomes by instability and selection

Antoine M. Snijders, Jane Fridlyand, Dorus A. Mans, Richard Segraves, Ajay N. Jain, Daniel Pinkel, Donna Albertson

Research output: Contribution to journalArticle

Abstract

Tumors with defects in mismatch repair (MMR) show fewer chromosomal changes by cytogenetic analyses than most solid tumors, suggesting that a greater proportion of the alterations required for malignancy occur in genes with nucleotide sequences susceptible to errors normally corrected by MMR. Here, we used genome-wide microarray comparative genomic hybridization to carry out a higher resolution evaluation of the effect of MMR competence on genomic alterations occurring in 20 cell lines and to determine if characteristic aberrations arise in MMR-proficient and -deficient HCT116 cells undergoing selection for methotrexate resistance. We observed different spectra of aberrations in MMR-proficient compared to -deficient cell lines, as well as among cell lines with different types of MMR-deficiency. We also observed different genetic routes to drug resistance. Resistant MMR-deficient cells most frequently displayed no copy number alterations (16/29 cell pools), whereas all MMR-proficient cells had unique abnormalities involving chromosome 5, including amplicons centered on the target gene, DHFR and/or a neighboring novel locus (7/13 pools). These observations support the concept that tumor genomes are shaped by selection for alterations that promote survival and growth advantage, as well as by the particular dysfunctions in genes responsible for maintenance of genetic integrity.

Original languageEnglish (US)
Pages (from-to)4370-4379
Number of pages10
JournalOncogene
Volume22
Issue number28
DOIs
StatePublished - Jul 10 2003

Fingerprint

DNA Mismatch Repair
Genomic Instability
Pharmaceutical Preparations
Neoplasms
Cell Line
Genome
Genes
HCT116 Cells
Chromosomes, Human, Pair 5
Comparative Genomic Hybridization
Cytogenetic Analysis
Drug Resistance
Methotrexate
Mental Competency
Maintenance
Growth

Keywords

  • Amplification
  • Array CGH
  • Genetic instability
  • Mismatch repair

ASJC Scopus subject areas

  • Cancer Research
  • Genetics
  • Molecular Biology

Cite this

Snijders, A. M., Fridlyand, J., Mans, D. A., Segraves, R., Jain, A. N., Pinkel, D., & Albertson, D. (2003). Shaping of tumor and drug-resistant genomes by instability and selection. Oncogene, 22(28), 4370-4379. https://doi.org/10.1038/sj.onc.1206482

Shaping of tumor and drug-resistant genomes by instability and selection. / Snijders, Antoine M.; Fridlyand, Jane; Mans, Dorus A.; Segraves, Richard; Jain, Ajay N.; Pinkel, Daniel; Albertson, Donna.

In: Oncogene, Vol. 22, No. 28, 10.07.2003, p. 4370-4379.

Research output: Contribution to journalArticle

Snijders, AM, Fridlyand, J, Mans, DA, Segraves, R, Jain, AN, Pinkel, D & Albertson, D 2003, 'Shaping of tumor and drug-resistant genomes by instability and selection', Oncogene, vol. 22, no. 28, pp. 4370-4379. https://doi.org/10.1038/sj.onc.1206482
Snijders AM, Fridlyand J, Mans DA, Segraves R, Jain AN, Pinkel D et al. Shaping of tumor and drug-resistant genomes by instability and selection. Oncogene. 2003 Jul 10;22(28):4370-4379. https://doi.org/10.1038/sj.onc.1206482
Snijders, Antoine M. ; Fridlyand, Jane ; Mans, Dorus A. ; Segraves, Richard ; Jain, Ajay N. ; Pinkel, Daniel ; Albertson, Donna. / Shaping of tumor and drug-resistant genomes by instability and selection. In: Oncogene. 2003 ; Vol. 22, No. 28. pp. 4370-4379.
@article{bc9fb548cb1647d681fdcddb4fd29f42,
title = "Shaping of tumor and drug-resistant genomes by instability and selection",
abstract = "Tumors with defects in mismatch repair (MMR) show fewer chromosomal changes by cytogenetic analyses than most solid tumors, suggesting that a greater proportion of the alterations required for malignancy occur in genes with nucleotide sequences susceptible to errors normally corrected by MMR. Here, we used genome-wide microarray comparative genomic hybridization to carry out a higher resolution evaluation of the effect of MMR competence on genomic alterations occurring in 20 cell lines and to determine if characteristic aberrations arise in MMR-proficient and -deficient HCT116 cells undergoing selection for methotrexate resistance. We observed different spectra of aberrations in MMR-proficient compared to -deficient cell lines, as well as among cell lines with different types of MMR-deficiency. We also observed different genetic routes to drug resistance. Resistant MMR-deficient cells most frequently displayed no copy number alterations (16/29 cell pools), whereas all MMR-proficient cells had unique abnormalities involving chromosome 5, including amplicons centered on the target gene, DHFR and/or a neighboring novel locus (7/13 pools). These observations support the concept that tumor genomes are shaped by selection for alterations that promote survival and growth advantage, as well as by the particular dysfunctions in genes responsible for maintenance of genetic integrity.",
keywords = "Amplification, Array CGH, Genetic instability, Mismatch repair",
author = "Snijders, {Antoine M.} and Jane Fridlyand and Mans, {Dorus A.} and Richard Segraves and Jain, {Ajay N.} and Daniel Pinkel and Donna Albertson",
year = "2003",
month = "7",
day = "10",
doi = "10.1038/sj.onc.1206482",
language = "English (US)",
volume = "22",
pages = "4370--4379",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "28",

}

TY - JOUR

T1 - Shaping of tumor and drug-resistant genomes by instability and selection

AU - Snijders, Antoine M.

AU - Fridlyand, Jane

AU - Mans, Dorus A.

AU - Segraves, Richard

AU - Jain, Ajay N.

AU - Pinkel, Daniel

AU - Albertson, Donna

PY - 2003/7/10

Y1 - 2003/7/10

N2 - Tumors with defects in mismatch repair (MMR) show fewer chromosomal changes by cytogenetic analyses than most solid tumors, suggesting that a greater proportion of the alterations required for malignancy occur in genes with nucleotide sequences susceptible to errors normally corrected by MMR. Here, we used genome-wide microarray comparative genomic hybridization to carry out a higher resolution evaluation of the effect of MMR competence on genomic alterations occurring in 20 cell lines and to determine if characteristic aberrations arise in MMR-proficient and -deficient HCT116 cells undergoing selection for methotrexate resistance. We observed different spectra of aberrations in MMR-proficient compared to -deficient cell lines, as well as among cell lines with different types of MMR-deficiency. We also observed different genetic routes to drug resistance. Resistant MMR-deficient cells most frequently displayed no copy number alterations (16/29 cell pools), whereas all MMR-proficient cells had unique abnormalities involving chromosome 5, including amplicons centered on the target gene, DHFR and/or a neighboring novel locus (7/13 pools). These observations support the concept that tumor genomes are shaped by selection for alterations that promote survival and growth advantage, as well as by the particular dysfunctions in genes responsible for maintenance of genetic integrity.

AB - Tumors with defects in mismatch repair (MMR) show fewer chromosomal changes by cytogenetic analyses than most solid tumors, suggesting that a greater proportion of the alterations required for malignancy occur in genes with nucleotide sequences susceptible to errors normally corrected by MMR. Here, we used genome-wide microarray comparative genomic hybridization to carry out a higher resolution evaluation of the effect of MMR competence on genomic alterations occurring in 20 cell lines and to determine if characteristic aberrations arise in MMR-proficient and -deficient HCT116 cells undergoing selection for methotrexate resistance. We observed different spectra of aberrations in MMR-proficient compared to -deficient cell lines, as well as among cell lines with different types of MMR-deficiency. We also observed different genetic routes to drug resistance. Resistant MMR-deficient cells most frequently displayed no copy number alterations (16/29 cell pools), whereas all MMR-proficient cells had unique abnormalities involving chromosome 5, including amplicons centered on the target gene, DHFR and/or a neighboring novel locus (7/13 pools). These observations support the concept that tumor genomes are shaped by selection for alterations that promote survival and growth advantage, as well as by the particular dysfunctions in genes responsible for maintenance of genetic integrity.

KW - Amplification

KW - Array CGH

KW - Genetic instability

KW - Mismatch repair

UR - http://www.scopus.com/inward/record.url?scp=0042092517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042092517&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1206482

DO - 10.1038/sj.onc.1206482

M3 - Article

VL - 22

SP - 4370

EP - 4379

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 28

ER -